Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|February 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations in the Prevention of Osteoporosis Among Postmenopausal Women
- Volume 4
- Issue 2 Suppl
Bibliography
Advertisement
Articles in this issue
over 28 years ago
Participating Facultyover 28 years ago
Current Approaches to Osteoporosis Preventionover 28 years ago
Patient-Provider Decisions About Long-Term Therapyover 28 years ago
Potential Impact of Emerging Therapies on Osteoporosis Preventionover 28 years ago
An Emerging Approach to Osteoporosis Preventionover 28 years ago
The Management of the Patient with Osteoporosis: A Modern Epidemicover 28 years ago
CME Quizover 28 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
New York Experts Push for Coordinated Obesity Care Teams
4
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
5